Clinical trial
Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of…
NCT00048425 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00048425 |
|---|---|
| Title | Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure. |
| Official title | Randomized, Multicenter Evaluation of Intravenous Levosimendan Efficacy Versus Placebo in the Short Term Treatment of Decompensated Chronic Heart Failure: the REVIVE II Study. |
| Lead sponsor | Abbott, Industry |
| Collaborators | Orion Corporation, Orion Pharma Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Heart Failure, Congestive |
| Intervention type | Drug |
| Interventions | Levosimendan |
| Enrollment | 600 |
| Start date | Sep 1, 2002 |
| Completion | Dec 1, 2004 |
| First posted | Nov 4, 2002 |
| Last update posted | Dec 15, 2006 |
| Countries | Australia, Canada, Israel, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: